LOGO
LOGO

Health News

FDA Achieves Goals In Reducing Animal Testing In Drug Development

By Joji Xavier   ✉  | Published:  | Google News Follow Us  | Join Us
fda 21042026 lt

The U.S. Food and Drug Administration has announced that vit achieved its key first-year goals in the implementation of its April 2025 Roadmap to Reducing Animal Testing in Preclinical Safety Studies, marking one year of transformative action to modernize drug development through innovative, human-relevant science.

"One year ago, we issued an ambitious road map to eliminate unnecessary animal testing and replace animal testing with more precise ways of predicting drug safety in humans," said FDA Commissioner Marty Makary. "In addition to ushering in more scientifically accurate way to test drugs before they are used in humans, the agency has made great strides to reduce research and development costs, which will lower drug prices for everyday Americans"

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Health News

Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.